Join
Live feed
·
INSIDERFilingvia Quantisnow
Precision BioSciences Inc. logo

President and CEO Amoroso Michael converted options into 9,443 shares and sold $24,668 worth of shares (3,012 units at $8.19), increasing direct ownership by 29% to 28,537 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DTIL· Precision BioSciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DTIL (Precision BioSciences Inc.) and more on Quantisnow.